Insider trades
Muthusamy Shanmugam, COO of Ani Pharmaceuticals ANIP, has filed 0 purchases and 67 sales on the open market. The latest trade was on 02/26.
Muthusamy Shanmugam
Head of R&d, COO-novitium Ops
- Company
- Ani Pharmaceuticals ANIP
- First filing
- 23/04/04
- Trades
- 76 trades
- Buys / sales
- 0 / 67
- 12-month net buying
- No record
- Last trade
- 02/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ANIP | Open-market sale | 25/08/20–25/08/21 | 25/08/22 | 100,000 sh2 trades | $90.36avg. | $9,036,007.96 | −18.8% |
ANIP | Open-market sale | 25/08/14–25/08/15 | 25/08/18 | 100,000 sh2 trades | $88.25avg. | $8,824,533.3 | −15.8% |
| Open-market sale10b5-1 plan | 25/05/09 | 25/05/13 | 700 sh | $76.83 | $53,781 | −0.1% | |
| Open-market sale10b5-1 plan | 24/07/18 | 24/07/19 | 2,743 sh | $62.00 | $170,066 | −0.4% | |
ANIP | Open-market sale10b5-1 plan | 24/07/15–24/07/17 | 24/07/17 | 47,257 sh3 trades | $63.73avg. | $3,011,592.12 | −6.9% |
| Open-market sale10b5-1 plan | 24/06/21 | 24/06/24 | 20,000 sh | $58.90 | $1,178,000 | −2.8% | |
ANIP | Open-market sale10b5-1 plan | 24/06/17–24/06/20 | 24/06/20 | 30,000 sh3 trades | $60.59avg. | $1,817,662.6 | −4.1% |
| Open-market sale10b5-1 plan | 24/05/20 | 24/05/21 | 12,855 sh | $61.81 | $794,567.55 | −1.7% | |
ANIP | Open-market sale10b5-1 plan | 24/05/15–24/05/17 | 24/05/17 | 37,145 sh3 trades | $64.37avg. | $2,391,120.8 | −4.7% |
ANIP | Open-market sale10b5-1 plan | 24/04/18–24/04/19 | 24/04/22 | 27,232 sh2 trades | $65.10avg. | $1,772,729.07 | −3.4% |
ANIP | Open-market sale10b5-1 plan | 24/04/15–24/04/17 | 24/04/17 | 22,768 sh3 trades | $65.91avg. | $1,500,589.42 | −2.7% |
| Open-market sale10b5-1 plan | 24/03/08 | 24/03/11 | 10,000 sh | $67.17 | $671,700 | −1.2% | |
ANIP | Open-market sale10b5-1 plan | 24/03/05–24/03/07 | 24/03/07 | 40,000 sh3 trades | $65.77avg. | $2,630,863.64 | −4.5% |
ANIP | Open-market sale10b5-1 plan | 24/01/19–24/01/23 | 24/01/23 | 25,216 sh3 trades | $56.17avg. | $1,416,466.08 | −2.8% |
ANIP | Open-market sale10b5-1 plan | 24/01/16–24/01/18 | 24/01/18 | 24,784 sh3 trades | $55.29avg. | $1,370,305.2 | −2.7% |
ANIP | Open-market sale10b5-1 plan | 23/12/15–23/12/19 | 23/12/19 | 50,000 sh3 trades | $52.55avg. | $2,627,250 | −5.1% |
ANIP | Open-market sale10b5-1 plan · Amendment | 23/11/14–23/11/17 | 23/11/20 | 50,000 sh4 trades | $52.48avg. | $2,624,147.61 | −4.8% |
ANIP | Open-market sale10b5-1 plan | 23/11/14–23/11/16 | 23/11/16 | 36,190 sh3 trades | $53.00avg. | $1,918,079.91 | −3.5% |
ANIP | Open-market sale10b5-1 plan | 23/10/17–23/10/19 | 23/10/19 | 25,000 sh3 trades | $57.75avg. | $1,443,868.5 | −2.4% |
ANIP | Open-market sale10b5-1 plan | 23/10/13–23/10/16 | 23/10/17 | 25,000 sh2 trades | $57.96avg. | $1,449,035.99 | −2.3% |